Genome-wide scanning for linkage in finnish breast cancer families

European Journal of Human Genetics

Volumn 12, Issue 2, 2004, Pages 98-104

  Huusko, Pia ^a,b   Hank Juo, Suh Hang ^c,d   Gillanders, Elizabeth ^a   Sarantaus, Laura ^c   Kainu, Tommi ^a   Vahteristo, Pia ^c   Allinen, Minna ^b   Jones, Mary Pat ^a   Rapakko, Katrin ^b   Eerola, Hannaleena ^c,d   Markey, Carol ^a   Vehmanen, Paula ^c   Gildea, Derek ^a   Freas Lutz, Diane ^a   Blomqvist, Carl ^c   Leiste, Jaakko ^b   Blanco, Guillermo ^b   Puistola, Ulla ^b   Trent, Jeffrey ^a   Bailey Wilson, Joan ^c   Winqvist, Robert ^b   Nevanlinna, Heli ^c   Kallioniemi, Olli P ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Breast cancer; Chromosome 2q; Finland; Genome wide linkage

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CHROMOSOME 13Q; CHROMOSOME 2Q; CONTROLLED STUDY; DOMINANT INHERITANCE; FINLAND; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM;

BASE SEQUENCE; BREAST NEOPLASMS; CHROMOSOME MAPPING; DNA PRIMERS; FINLAND; HUMANS; LINKAGE (GENETICS);

EID: 10744223689     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201091     Document Type: Article

References (34)

1. Ford D, Easton DF, Stratton M et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-689.
2. Rebbeck TR, Couch FJ, Kant J et al: Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 1996; 59: 547-553.
3. Serova OM, Mazoyer S, Puget N et al: Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 1997; 60: 486-495.
4. Schubert EL, Lee MK, Mefford HC et al: BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 1997; 60: 1031-1040.
5. Vehmanen P, Friedman LS, Eerola H et al: Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 1997; 13: 2309-2315.
6. Roa BB, Boyd AA, Volcik K, Richards CS: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996; 4: 185-187.
7. Vehmanen P, Friedman LS, Eerola H et al: A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 1997; 60: 1050-1058.
8. Huusko P, Paakkonen K, Launonen V et al: Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. Am J Hum Genet 1998; 62: 1544-1548.
9. Seitz S, Rohde K. Bender E et al: Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene 1997; 14: 741-743.
10. Kainu T, Juo S-H, Desper R et al: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci USA 2000; 97: 9603-9608.
11. Rahman N, Teare MD, Seal S et al: Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene 2000; 19: 4170-4173.
12. Thompson D, Szabo CI, Mangion J et al: Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 2002; 99: 827-831.
13. Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton D: Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001; 21: 1-18.
14. Cui J, Antoniou AC, Dite GS et al: After BRCA1 and BRCA2 - What next? Multifactorial segragation analysis of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 2001; 68: 420-431.
15. Antoniou AC, Pharoah PDP, McMullan G et al: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86: 76-83.
16. Lahti-Domenici J, Rapakko K, Paakkonen K et al: Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet 2001; 129: 120-123.
17. Meijers-Heijboer H, van den Ouweland A, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55-59,
18. Vahteristo P, Bartkova J, Eerola H et al: A CHEK2 variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432-438.
19. O'Connell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266,
20. Broman KW, Weber JL: Estimation of pairwise relationships in the presence of genotyping errors. Am J Hum Genet 1998; 63: 1563-1564.
21. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232-242.
22. Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993; 52: 678-701.
23. Goring HH, Terwilliger JD: Linkage analysis in the presence of errors III: marker loci and their map as nuisance parameters. Am J Hum Genet 2000; 66: 1298-1309.
24. Goring HH, Terwilliger JD: Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. Am J Hum Genet 2000; 66: 1310-1327.
25. Lathrop GM, Lalouel JM, Julier C, Ott J: Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984; 81: 3443-3446,
26. Cottingham RW, Idury RM, Schäffer AA: Faster sequential genetic linkage computations. Am J Hum Genet 1993; 53: 252-263.
27. Schaffer AA, Gupta SK, Shriram K, Cottingham RW: Avoiding recomputation in linkage analysis. Hum Hered 1994; 44: 225-237.
28. Xu J, Meyers D, Freije D et al: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 175-179.
29. Rapley EA, Crockford GP, Teare D et al: Localization to Xq27 of a susceptibility gene for germ-cell tumours. Nat Genet 2000; 24: 197-200.
30. Cui J, Hopper JL: Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study. Cancer Epidemiol Biomarkers Prev 2000; 9: 805-812.
31. Malkin D, Li FP, Strong LC et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250: 1233-1238.
32. Nelen MR, Padberg GW, Peeters EAJ et al: Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13: 14-116.
33. Savitsky K, Bar-Shira A, Gilad S et al: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-1753.
34. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-36.